A Novel Hypothesis on Choroideremia-Manifesting Female Carriers: Could CHM In-Frame Variants Exert a Dominant Negative Effect? A Case Report
Authors:
- Niccolò Di GiosaffatteNGNiccolò Di Giosaffatte
- Michele ValianteMVMichele Valiante
- Stefano TricaricoSTStefano Tricarico
- Giulia PariseGPGiulia Parise
- Anna Maria De NegriANAnna Maria De Negri
- Guido RicciottiGRGuido Ricciotti
- Lara FloreanLFLara Florean
- Alessandro PaiardiniAlessandro Paiardini
- Irene BottilloIrene Bottillo
- Paola GrammaticoPGPaola Grammatico
Open Access
Abstract
Choroideremia is an X-linked recessive condition presenting in males, with progressive degeneration of retinal and choroidal tissues leading to progressive visual loss. Its pathological mechanism is due to alterations in the CHM gene that encodes for REP1, a protein required for prenylation of Rab by the Rab geranylgeranyl transferase (RGGT). Even though female carriers are predicted to be not affected by the disease, a wide phenotypic spectrum ranging from mild to severe cases has been reported in women. The reason why Choroideremia manifests in female carriers remains elusive. While X chromosome inactivation (XCI) skewing has been proposed as a leading putative mechanism, emerging evidence has shown that CHM could variably escape from XCI. We described a family with an initial clinical suspicion of Retinitis Pigmentosa in which a novel CHM pathogenic splicing variant was found by exome sequencing. The variant, initially found in the 63-year-old female presenting with impaired visual acuity and severe retinal degeneration, segregated in the 31-year-old daughter and the 37-year-old son, both presenting with fundus anomalies. mRNA studies revealed a shorter in-frame CHM isoform lacking exon 10. Molecular modeling of the ternary REP1/Rab/RGGT protein complex predicted significant impairing of REP1/Rab binding without alteration of REP1/RGGT interaction. We suggest that, in our female cases, the biallelic expression of CHM may have led to the production of both the mutant and wild type REP1. The mutant isoform, sequestrating RGGT, could reduce its available amount for Rab prenylation, thus exerting a dominant-negative effect. If confirmed with further studies and in large cohorts of female carriers, the here proposed molecular mechanism could help to explain the complexity of manifestation of Choroideremia in females.Keywords
This publication has 23 references indexed in Scilit:
- Choroideremia: A review of general findings and pathogenesisOphthalmic Genetics, 2011
- CHM gene molecular analysis and X‐chromosome inactivation pattern determination in two families with choroideremiaAmerican Journal of Medical Genetics Part A, 2009
- Rab geranylgeranylation occurs preferentially via the pre-formed REP–RGGT complex and is regulated by geranylgeranyl pyrophosphateBiochemical Journal, 2008
- Structures of RabGGTase–substrate/product complexes provide insights into the evolution of protein prenylationThe EMBO Journal, 2008
- Comparative Protein Structure Modeling Using ModellerCurrent Protocols in Bioinformatics, 2006
- X-inactivation profile reveals extensive variability in X-linked gene expression in femalesNature, 2005
- Structure of the Rab7:REP-1 ComplexCell, 2004
- Structure of Rab Escort Protein-1 in Complex with Rab GeranylgeranyltransferaseMolecular Cell, 2003
- Evaluation of PSI‐BLAST alignment accuracy in comparison to structural alignmentsProtein Science, 2000
- CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choiceNucleic Acids Research, 1994